Skip to main content
    I

    Invivyd Inc. (IVVD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.51
    -0.03 (-4.67%)

    Market Cap: $158.49M

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Invivyd Inc. (IVVD) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Invivyd (IVVD) has a market cap of $158.49M and an enterprise value of $32.09M. Its share count is up 89.48% from a year earlier. It kept -214.77% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 79.75% below the market cap, as cash exceeds debt.

    Market Cap$158.49M
    Enterprise Value$32.09M
    Latest price (Nov 17, 2026)$0.51

    Key Dates

    The next earnings report is expected on Mar 1, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 1, 2027 (expected)
    Last Earnings DateNov 16, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.62% in the quarter ended Sep 30, 2026 and grew 64.26% a year over 2 years.

    Shares Outstanding322.43M
    Shares Change (YoY)+89.48%
    Shares Change (QoQ)+0.62%
    Share Count Growth (2Y CAGR)+64.26%

    Valuation Ratios

    Sales and book value multiples are 2.7x and 1.1x. Its year-end P/S ranged from 2.1x to 143.1x from 2023 to 2025.

    P/S Ratio2.7x
    Forward P/S2.6x
    P/B Ratio1.1x

    Valuation history and multiples

    Price Statistics

    The stock is down 78.19% over 52 weeks and trades 28.17% below its 50-day average.

    Beta (1Y)2.10
    52-Week Change-78.19%
    1-Month Change-15.97%
    3-Month Change-46.58%
    6-Month Change-50.71%
    5-Year Change-98.01%
    Total Return (1Y)-78.19%
    Total Return (3Y CAGR)-29.12%
    Total Return (5Y CAGR)-51.73%
    Max Drawdown (1Y)-82.20%
    Max Drawdown (3Y)-92.90%
    Sharpe Ratio (1Y)-1.63
    Correlation with SPY (1Y)0.29
    50-Day Average$0.71
    200-Day Average$1.07
    52-Week Range$0.52 to $3.01
    RSI (14 Days)35.7
    Average Volume (20 Days)4.01M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.51x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio5.51x
    Quick Ratio5.51x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -86.61% over the last 12 months, against a 5-year average of -98.74%.

    Return on Equity (ROE)-86.61%
    Return on Assets (ROA)-70.87%
    Return on Capital Employed (ROCE)-82.97%
    ROE (5Y Average)-98.74%
    ROA (5Y Average)-67.28%
    ROIC (5Y Average)-17.17%
    Asset Turnover0.38x
    Receivables Turnover5.18x

    Scores

    IVVD has an Altman Z-Score of -6.43, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-6.43
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $60.69M over the last 12 months is up 21.28% from the 12 months before.

    Revenue$60.69M
    Revenue Growth (YoY)+21.28%
    Gross Profit$56.20M
    Operating Income-$136.19M
    Pretax Income-$130.33M
    Net Income-$130.33M
    EBITDA-$128.10M
    EBIT-$130.33M
    Reported EPS (TTM)-$0.41

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 81.82% of the $183.91M in total assets.

    Cash and Equivalents$126.40M
    Total Debt$0
    Net Cash$126.40M
    Net Cash Per Share$0.39
    Working Capital$121.03M
    Shareholder Equity$150.48M
    Book Value Per Share$0.47
    Total Assets$183.91M
    Total Liabilities$33.42M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.82M of capital spending, operating cash flow left -$134.11M of free cash flow.

    Operating Cash Flow-$132.29M
    Capital Expenditures$1.82M
    Free Cash Flow-$134.11M
    FCF Per Share-$0.45
    Depreciation and Amortization$2.23M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -224.42%.

    Gross Margin92.60%
    Operating Margin-224.42%
    Pretax Margin-214.77%
    Net Margin-214.77%
    EBITDA Margin-211.08%
    EBIT Margin-214.77%
    FCF Margin-220.99%

    Growth

    Book Value Per Share Growth (2Y CAGR)-6.82%
    Tangible Book Per Share Growth (2Y CAGR)-6.82%

    Revenue and profit by year

    Dividends and Yields

    IVVD does not pay a dividend.

    Buyback Yield-78.01%
    Shareholder Yield-78.01%

    Peer Position

    Against 8 similar companies, IVVD has the 8th highest P/S.

    P/S Ratio2.7x vs 14.9x median
    Revenue Growth (Trailing 4 Quarters, YoY)+21.28% vs -33.45% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 27.60% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+27.60%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About IVVD

    What is IVVD's market cap?

    Invivyd has a market cap of $158.49M. Its enterprise value, which adds debt and subtracts cash, is $32.09M.

    How many shares of IVVD are outstanding?

    Invivyd has 322.43M shares outstanding. The count is up 89.48% from a year earlier.

    Does IVVD pay a dividend?

    No. Invivyd does not pay a dividend.

    How much debt does IVVD have?

    Invivyd has $0 of total debt and $126.40M of cash and equivalents, a net cash position of $126.40M.